Acadian Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Other funds holding ORIC
Acadian Asset Management's ORIC Position: Q3 2026 in Review
Acadian Asset Management opened a new position in Oric Pharmaceuticals (ORIC) in Q3 2026: 8,093 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #1724 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in ORIC as recently as Q1 2026.
Acadian Asset Management first reported a position in ORIC in Q1 2022 and has held it in 10 quarters since. The position peaked at $1.32M in Q2 2023. 203 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.
- Acadian Asset Management held 8,093 shares of Oric Pharmaceuticals worth $108K as of Q3 2026.
- Oric Pharmaceuticals was a new Acadian Asset Management position in Q3 2026.
- Oric Pharmaceuticals made up ﹤0.01% of Acadian Asset Management's portfolio in Q3 2026, its #1724 holding.
- Acadian Asset Management first reported a position in Oric Pharmaceuticals in Q1 2022 and has held it in 10 quarters since.
- Acadian Asset Management's Oric Pharmaceuticals position peaked at $1.32M in Q2 2023.
- 203 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.
Based on Acadian Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.